Patents by Inventor Jang Kyoung KIM

Jang Kyoung KIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Adipocyte-targeting non-viral gene delivery system
    Patent number: 9765329
    Abstract: The present invention relates to a gene delivery system for targeting adipocytes and a treatment system for obesity and obesity-derived metabolic syndromes using the same and, more particularly, to a non-viral gene delivery system which directly targets a differentiated obesity (mature) adipocyte and contains an adipocyte targeting sequence (ATS)-arginine (R9) peptide.
    Type: Grant
    Filed: March 31, 2014
    Date of Patent: September 19, 2017
    Assignee: INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY
    Inventors: Yong-Hee Kim, Kwang-Suk Lim, Young-Wook Won, Jang-Kyoung Kim
  • Low molecular weight methyl cellulose-based parenteral drug delivery system
    Patent number: 9700630
    Abstract: The present invention relates to a parenteral drug delivery carrier and a drug delivery system that use a thermosensitive gel based on methyl cellulose alone as a low molecular weight polysaccharide without a salting-out salt. The single use of the low molecular weight methyl cellulose as a natural polymer increases the biocompatibility and biodegradability of the drug delivery system. Therefore, the drug delivery system is suitable for use in the preparation of a sustained release composition for parenteral drug delivery.
    Type: Grant
    Filed: May 9, 2014
    Date of Patent: July 11, 2017
    Assignee: INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY
    Inventors: Yong-Hee Kim, Jang Kyoung Kim
  • ADIPOCYTE-TARGETING NON-VIRAL GENE DELIVERY SYSTEM
    Publication number: 20160130579
    Abstract: The present invention relates to a gene delivery system for targeting adipocytes and a treatment system for obesity and obesity-derived metabolic syndromes using the same and, more particularly, to a non-viral gene delivery system which directly targets a differentiated obesity (mature) adipocyte and contains an adipocyte targeting sequence (ATS)-arginine (R9) peptide.
    Type: Application
    Filed: March 31, 2014
    Publication date: May 12, 2016
    Applicant: Industry-University Cooperation Foundation Hanyang University
    Inventors: Yong-Hee KIM, Kwang-Suk LIM, Young-Wook WON, Jang-Kyoung KIM
  • LOW MOLECULAR WEIGHT METHYL CELLULOSE-BASED PARENTERAL DRUG DELIVERY SYSTEM
    Publication number: 20160106848
    Abstract: The present invention relates to a parenteral drug delivery carrier and a drug delivery system that use a thermosensitive gel based on methyl cellulose alone as a low molecular weight polysaccharide without a salting-out salt. The single use of the low molecular weight methyl cellulose as a natural polymer increases the biocompatibility and biodegradability of the drug delivery system. Therefore, the drug delivery system is suitable for use in the preparation of a sustained release composition for parenteral drug delivery.
    Type: Application
    Filed: May 9, 2014
    Publication date: April 21, 2016
    Applicant: INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY
    Inventors: Yong-Hee KIM, Jang Kyoung KIM